These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8202218)

  • 1. Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30)NH2 on the GH release in rats.
    Kovács M; Fáncsik A; Mezö I; Teplán I; Flerkó B
    Neuroendocrinology; 1994 Apr; 59(4):371-9. PubMed ID: 8202218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30)-NH2 on the GH release in rats treated with monosodium glutamate.
    Kovács M; Fáncsik A; Hrabovsky E; Mezö I; Teplán I; Flerkó B
    J Neuroendocrinol; 1995 Sep; 7(9):703-12. PubMed ID: 8547948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity.
    Mezö I; Kovács M; Szöke B; Szabó EZ; Horváth J; Makara GB; Rappay G; Tamás J; Teplán I
    J Endocrinol Invest; 1993 Nov; 16(10):793-8. PubMed ID: 8144853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of a new potent agonist of growth hormone- releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action.
    Kovács M; Halmos G; Groot K; Izdebski J; Schally AV
    Neuroendocrinology; 1996 Sep; 64(3):169-76. PubMed ID: 8875434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of a new potent agonist of GH-RH(1-29)NH2 on linear growth and GH responsiveness in rats.
    Pinski J; Izdebski J; Jungwirth A; Groot K; Schally AV
    Regul Pept; 1996 Sep; 65(3):197-201. PubMed ID: 8897642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of intravenous, subcutaneous, and in vitro activity of new agmatine analogs of growth hormone-releasing hormone hGH-RH (1-29)NH2.
    Kovacs M; Gulyas J; Bajusz S; Schally AV
    Life Sci; 1988; 42(1):27-35. PubMed ID: 2892105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent agonists of growth hormone-releasing hormone. Part I.
    Zarandi M; Serfozo P; Zsigo J; Bokser L; Janaky T; Olsen DB; Bajusz S; Schally AV
    Int J Pept Protein Res; 1992 Mar; 39(3):211-7. PubMed ID: 1399259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vivo [corrected] biological activity of new agmatine analogs of growth hormone-releasing hormone (GH-RH).
    Bokser L; Zarandi M; Schally AV
    Life Sci; 1990; 46(14):999-1005. PubMed ID: 2109164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone (GH)-releasing hormone and its analogs on GH secretion from cultured adenohypophysial cells in cattle.
    Soliman EB; Hashizume T; Ohashi S; Kanematsu S
    Domest Anim Endocrinol; 1997 Jan; 14(1):39-46. PubMed ID: 8985668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.
    Varga JL; Schally AV; Csernus VJ; Zarándi M; Halmos G; Groot K; Rékási Z
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):692-7. PubMed ID: 9892695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).
    Kovács M; Schally AV; Zarándi M; Groot K
    Peptides; 1997; 18(3):431-8. PubMed ID: 9145432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional reduction of somatostatin concentration interacted with rat growth hormone releasing hormone to titrate the magnitude of pulsatile growth hormone and prolactin release in perifusion.
    Stachura ME; Tyler JM; Farmer PK
    Neuroendocrinology; 1988 Nov; 48(5):500-6. PubMed ID: 2907614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationships.
    Vance ML; Evans WS; Kaiser DL; Burke RL; Rivier J; Vale W; Thorner MO
    Clin Pharmacol Ther; 1986 Dec; 40(6):627-33. PubMed ID: 3096623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogs of growth hormone-releasing hormone induce release of growth hormone in the bovine.
    Scarborough R; Gulyas J; Schally AV; Reeves JJ
    J Anim Sci; 1988 Jun; 66(6):1386-92. PubMed ID: 3135287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Gaba-containing analogues of human growth hormone releasing hormone (1-30)-amide: II. Detailed in vivo biological examinations.
    Kovács M; Mezõ I; Teplán I; Hollósi M; Kajtár J; Flerkó B
    J Endocrinol Invest; 1993 Nov; 16(10):799-805. PubMed ID: 8144854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.
    Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased pituitary growth hormone response to growth hormone-releasing factor in cafeteria-fed rats: dietary and obesity effects.
    Renier G; Gaudreau P; Hajjad H; Deslauriers N; Houde-Nadeau M; Brazeau P
    Neuroendocrinology; 1990 Sep; 52(3):284-90. PubMed ID: 2145525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.